US · guidance
CMS Pub. 100-04, ch. 32, § 260
Dermal Injections for Treatment of Facial Lipodystrophy Syndrome
(LDS)
(Rev. 2105, Issued: 11-24-10, Effective: 03-23-10, Implementation: 07-06-10)
History
(Rev. 2105, Issued: 11-24-10, Effective: 03-23-10, Implementation: 07-06-10)
Provenance
- Source
- cms.gov
- Retrieved
- 2026-08-25
- Edition
- iom-2026-08-25
- Content hash
b9bc0e3a7c4a06469ca799fe8e65c1eeb7617c3559c739ba02af0ad33c1c9d89
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.